Data views / Suppliers with repeat OAI inspections

Suppliers with more than one OAI inspection

48 records Updated 9 July 2026

48 suppliers in this directory have been classified Official Action Indicated on more than one inspection. A single OAI can be remediated; a repeat is the strongest published signal that problems are unresolved.

All 48

SupplierOAI inspectionsLatest inspectionPlantsCountry
Megafine Pharma (P) 6VAI 20234India
Meridian Medical Technologies 6VAI 20242United States
Aurobindo Pharma 4OAI 202512India
Baxter Healthcare 4OAI 202512United States
Zhuhai United Laboratories 4OAI 20234China
Kyowa Hakko Bio 4NAI 20243Japan
Marcus Research Laboratory 4VAI 20241United States
Glenmark Pharmaceuticals s.r.o 3NAI 202412Czech Republic
Antibioticos Do Brasil Ltda 3NAI 20228Brazil
Laboratorio Reig Jofre 3OAI 20238Spain
Jubilant Generics 3VAI 20245India
Zhejiang Huahai Pharmaceutical 3OAI 20255China
ALK-Abelló A/S 3OAI 20254United States
Dental Technologies 3VAI 20242United States
Hill Dermaceuticals 3VAI 20252United States
KVK-Tech 3OAI 20252United States
Rising 3VAI 20222United States
Alchymars ICM SM 3OAI 20251India
Pharma Nobis 3VAI 20251United States
Somerset Therapeutics 3OAI 20251India
Fresenius Kabi 2NAI 202585Sweden
Cadila Pharmaceuticals 2NAI 202520India
Macleods Pharmaceuticals 2VAI 202420India
Cipla 2VAI 202512India
USV 2VAI 20259India
Bausch & Lomb 2NAI 20257United States
Centaur Pharmaceuticals 2VAI 20255India
Onesource Specialty Pharma 2VAI 20255India
J.M. Huber Micropowders 2OAI 20253United States
Panacea Biotec Pharma 2OAI 20233India
Valens Molecules 2VAI 20243India
Zhejiang Tianyu Pharmaceutical 2VAI 20243China
Taiwan Biotech 2OAI 20222Taiwan
Yuki Gosei Kogyo 2VAI 20262Japan
Advance Pharmaceutical 2VAI 20251United States
Altaire Pharmaceuticals 2OAI 20221United States
Apozeal Pharmaceuticals 2OAI 20251United States
Cetylite Industries 2VAI 20241United States
ChemPacific 2VAI 20241United States
Cheng Fong Chemical 2VAI 20241Taiwan
Chongqing Carelife Pharmaceutical 2NAI 20251China
Keshava Organics 2VAI 20231India
Kreative Organics 2VAI 20251India
Lgm Pharma 2VAI 20241United States
Sato Pharmaceutical 2OAI 20251Japan
Scientific Protein Laboratories 2OAI 20251United States
Tris Pharma 2VAI 20251United States
Winder Laboratories 2OAI 20251United States

Where these figures come from

Every number on this page is counted from published registers — nothing is modelled or estimated. Records last refreshed 9 July 2026. How we count our figures.

Source
FDA inspection classifications

Questions

What does OAI mean?
Official Action Indicated is the FDA's worst inspection classification. It means objectionable conditions were found and regulatory action is warranted. The milder outcomes are VAI (Voluntary Action Indicated) and NAI (No Action Indicated).
How many suppliers have a repeat OAI?
48 have two or more. A further 89 have exactly one.
Does an OAI mean the supplier is barred?
No. OAI is an inspection classification, not an import alert or a warning letter, and sites frequently remediate. It does mean the site warrants scrutiny before qualification.
How recent are these classifications?
From published FDA inspection classifications, with records last refreshed 2026-07-09. The latest inspection date is shown on every row so you can see whether the history is current or historic.

Run this against your own list

Tell us the molecules and markets you file in. These suppliers come back tiered for those markets, with the price corridor and an RFI sheet.

Start for free
No sales call.

Related views

Suppliers with GMP from 2+ regulators 972 FDA inspection outcomes by country 16 Active FDA Type II DMF holders 1,130

Browse the directory

Molecules Suppliers Combinations All data views